Martin Edwards
CIK 1640073 · last filed 2025-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
32
Lifetime Open-Market Net
-$55.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc (VRNA) Delisted | Director | 72,000 | $106.91 | $7.70M | -$103.8K | 10 | 2025-10-08 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 5 | 2024-06-20 |
| Morphic Holding, Inc. (MORF) Delisted | Director | 2,376 | $56.99 | $135.4K | $48.8K | 7 | 2024-06-05 |
| REATA PHARMACEUTICALS INC (RETA) Delisted | Director | 0 | $172.36 | $0 | $0 | 6 | 2023-09-26 |
| KALV | Director | — | $27.00 | — | $0 | 3 | 2021-10-04 |
Recent Filings · Page 3 of 4
32 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-04 | KALV | Grant (A) | — | $0 | EDGAR |
| 2021-08-10 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-24 | Inozyme Pharma, Inc. (INZY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-05 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −12,024 | -$10.1K | EDGAR |
| 2021-02-03 | Verona Pharma plc (VRNA) Delisted | Sell (S) | −13,688 | -$13.6K | EDGAR |
| 2020-12-03 | Morphic Holding, Inc. (MORF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-02 | KALV | Grant (A) | — | $0 | EDGAR |
| 2020-08-04 | REATA PHARMACEUTICALS INC (RETA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.